Browsing Centre for Experimental Cancer Medicine by Author "Santhanam, S"
Now showing items 1-1 of 1
-
Phase III, Double-Blind, Randomized Trial That Compared Maintenance Lapatinib Versus Placebo After First-Line Chemotherapy in Patients With Human Epidermal Growth Factor Receptor 1/2-Positive Metastatic Bladder Cancer.
Powles, T; Huddart, RA; Elliott, T; Sarker, S-J; Ackerman, C; Jones, R; Hussain, S; Crabb, S; Jagdev, S; Chester, J (2017-01)Purpose To establish whether maintenance lapatinib after first-line chemotherapy is beneficial in human epidermal growth factor receptor (HER) 1/HER2-positive metastatic urothelial bladder cancer (UBC). Methods Patients ...